-
Description
-
Table of Contents
-
Table of Figures
-
Related Reports
PDF Download
-
Description
-
Table of Contents
-
Table of Figures
-
Related Reports
- PDF Download
Description
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The global market for Emphysema Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Emphysema Treatment by region & country, by Type, and by Application.
The Emphysema Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment.
Market Segmentation
Report Metric
Details
Report Title
Emphysema Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Emphysema Treatment Companies Covered
Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus, BTG, PneumRx and Uptake Medical, Halozyme Therapeutics, Mariposa Health, Uptake Medical
Global Emphysema Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Emphysema Treatment Market, Segment by Type
Global Emphysema Treatment Market, Segment by Application
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Emphysema Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Emphysema Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Emphysema Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Emphysema Treatment Product Introduction
1.2 Global Emphysema Treatment Market Size Forecast
1.3 Emphysema Treatment Market Trends & Drivers
1.3.1 Emphysema Treatment Industry Trends
1.3.2 Emphysema Treatment Market Drivers & Opportunity
1.3.3 Emphysema Treatment Market Challenges
1.3.4 Emphysema Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Emphysema Treatment Players Revenue Ranking (2023)
2.2 Global Emphysema Treatment Revenue by Company (2019-2024)
2.3 Key Companies Emphysema Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Emphysema Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Emphysema Treatment
2.6 Emphysema Treatment Market Competitive Analysis
2.6.1 Emphysema Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Emphysema Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Centrilobular emphysema
3.1.2 Panlobular emphysema
3.2 Global Emphysema Treatment Sales Value by Type
3.2.1 Global Emphysema Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Emphysema Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Emphysema Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Surgical center
4.2 Global Emphysema Treatment Sales Value by Application
4.2.1 Global Emphysema Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Emphysema Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Emphysema Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Emphysema Treatment Sales Value by Region
5.1.1 Global Emphysema Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Emphysema Treatment Sales Value by Region (2019-2024)
5.1.3 Global Emphysema Treatment Sales Value by Region (2025-2030)
5.1.4 Global Emphysema Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Emphysema Treatment Sales Value, 2019-2030
5.2.2 North America Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Emphysema Treatment Sales Value, 2019-2030
5.3.2 Europe Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Emphysema Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Emphysema Treatment Sales Value, 2019-2030
5.5.2 South America Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Emphysema Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Emphysema Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Emphysema Treatment Sales Value
6.3 United States
6.3.1 United States Emphysema Treatment Sales Value, 2019-2030
6.3.2 United States Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Emphysema Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Emphysema Treatment Sales Value, 2019-2030
6.4.2 Europe Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Emphysema Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Emphysema Treatment Sales Value, 2019-2030
6.5.2 China Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Emphysema Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Emphysema Treatment Sales Value, 2019-2030
6.6.2 Japan Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Emphysema Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Emphysema Treatment Sales Value, 2019-2030
6.7.2 South Korea Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Emphysema Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Emphysema Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Emphysema Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Emphysema Treatment Sales Value, 2019-2030
6.9.2 India Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Emphysema Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pulmonx
7.1.1 Pulmonx Profile
7.1.2 Pulmonx Main Business
7.1.3 Pulmonx Emphysema Treatment Products, Services and Solutions
7.1.4 Pulmonx Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Pulmonx Recent Developments
7.2 Bioxyne
7.2.1 Bioxyne Profile
7.2.2 Bioxyne Main Business
7.2.3 Bioxyne Emphysema Treatment Products, Services and Solutions
7.2.4 Bioxyne Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Bioxyne Recent Developments
7.3 Intrexon
7.3.1 Intrexon Profile
7.3.2 Intrexon Main Business
7.3.3 Intrexon Emphysema Treatment Products, Services and Solutions
7.3.4 Intrexon Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Icure Pharmaceuticals Recent Developments
7.4 Icure Pharmaceuticals
7.4.1 Icure Pharmaceuticals Profile
7.4.2 Icure Pharmaceuticals Main Business
7.4.3 Icure Pharmaceuticals Emphysema Treatment Products, Services and Solutions
7.4.4 Icure Pharmaceuticals Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Icure Pharmaceuticals Recent Developments
7.5 Kamada
7.5.1 Kamada Profile
7.5.2 Kamada Main Business
7.5.3 Kamada Emphysema Treatment Products, Services and Solutions
7.5.4 Kamada Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Kamada Recent Developments
7.6 Emphasys Medical
7.6.1 Emphasys Medical Profile
7.6.2 Emphasys Medical Main Business
7.6.3 Emphasys Medical Emphysema Treatment Products, Services and Solutions
7.6.4 Emphasys Medical Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Emphasys Medical Recent Developments
7.7 Pfizer
7.7.1 Pfizer Profile
7.7.2 Pfizer Main Business
7.7.3 Pfizer Emphysema Treatment Products, Services and Solutions
7.7.4 Pfizer Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Pfizer Recent Developments
7.8 Olympus
7.8.1 Olympus Profile
7.8.2 Olympus Main Business
7.8.3 Olympus Emphysema Treatment Products, Services and Solutions
7.8.4 Olympus Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Olympus Recent Developments
7.9 BTG
7.9.1 BTG Profile
7.9.2 BTG Main Business
7.9.3 BTG Emphysema Treatment Products, Services and Solutions
7.9.4 BTG Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 BTG Recent Developments
7.10 PneumRx and Uptake Medical
7.10.1 PneumRx and Uptake Medical Profile
7.10.2 PneumRx and Uptake Medical Main Business
7.10.3 PneumRx and Uptake Medical Emphysema Treatment Products, Services and Solutions
7.10.4 PneumRx and Uptake Medical Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 PneumRx and Uptake Medical Recent Developments
7.11 Halozyme Therapeutics
7.11.1 Halozyme Therapeutics Profile
7.11.2 Halozyme Therapeutics Main Business
7.11.3 Halozyme Therapeutics Emphysema Treatment Products, Services and Solutions
7.11.4 Halozyme Therapeutics Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Halozyme Therapeutics Recent Developments
7.12 Mariposa Health
7.12.1 Mariposa Health Profile
7.12.2 Mariposa Health Main Business
7.12.3 Mariposa Health Emphysema Treatment Products, Services and Solutions
7.12.4 Mariposa Health Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Mariposa Health Recent Developments
7.13 Uptake Medical
7.13.1 Uptake Medical Profile
7.13.2 Uptake Medical Main Business
7.13.3 Uptake Medical Emphysema Treatment Products, Services and Solutions
7.13.4 Uptake Medical Emphysema Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 Uptake Medical Recent Developments
8 Industry Chain Analysis
8.1 Emphysema Treatment Industrial Chain
8.2 Emphysema Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Emphysema Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Emphysema Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Emphysema Treatment Market Trends
Table 2. Emphysema Treatment Market Drivers & Opportunity
Table 3. Emphysema Treatment Market Challenges
Table 4. Emphysema Treatment Market Restraints
Table 5. Global Emphysema Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Emphysema Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Emphysema Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Emphysema Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Emphysema Treatment
Table 10. Global Emphysema Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Emphysema Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Emphysema Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Emphysema Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Emphysema Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Emphysema Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Emphysema Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Emphysema Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Emphysema Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Emphysema Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Emphysema Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Emphysema Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Emphysema Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Emphysema Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Emphysema Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Emphysema Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Emphysema Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Emphysema Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Emphysema Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Pulmonx Basic Information List
Table 32. Pulmonx Description and Business Overview
Table 33. Pulmonx Emphysema Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Emphysema Treatment Business of Pulmonx (2019-2024)
Table 35. Pulmonx Recent Developments
Table 36. Bioxyne Basic Information List
Table 37. Bioxyne Description and Business Overview
Table 38. Bioxyne Emphysema Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Emphysema Treatment Business of Bioxyne (2019-2024)
Table 40. Bioxyne Recent Developments
Table 41. Intrexon Basic Information List
Table 42. Intrexon Description and Business Overview
Table 43. Intrexon Emphysema Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Emphysema Treatment Business of Intrexon (2019-2024)
Table 45. Intrexon Recent Developments
Table 46. Icure Pharmaceuticals Basic Information List
Table 47. Icure Pharmaceuticals Description and Business Overview
Table 48. Icure Pharmaceuticals Emphysema Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Emphysema Treatment Business of Icure Pharmaceuticals (2019-2024)
Table 50. Icure Pharmaceuticals Recent Developments
Table 51. Kamada Basic Information List
Table 52. Kamada Description and Business Overview
Table 53. Kamada Emphysema Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Emphysema Treatment Business of Kamada (2019-2024)
Table 55. Kamada Recent Developments
Table 56. Emphasys Medical Basic Information List
Table 57. Emphasys Medical Description and Business Overview
Table 58. Emphasys Medical Emphysema Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Emphysema Treatment Business of Emphasys Medical (2019-2024)
Table 60. Emphasys Medical Recent Developments
Table 61. Pfizer Basic Information List
Table 62. Pfizer Description and Business Overview
Table 63. Pfizer Emphysema Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Emphysema Treatment Business of Pfizer (2019-2024)
Table 65. Pfizer Recent Developments
Table 66. Olympus Basic Information List
Table 67. Olympus Description and Business Overview
Table 68. Olympus Emphysema Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Emphysema Treatment Business of Olympus (2019-2024)
Table 70. Olympus Recent Developments
Table 71. BTG Basic Information List
Table 72. BTG Description and Business Overview
Table 73. BTG Emphysema Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Emphysema Treatment Business of BTG (2019-2024)
Table 75. BTG Recent Developments
Table 76. PneumRx and Uptake Medical Basic Information List
Table 77. PneumRx and Uptake Medical Description and Business Overview
Table 78. PneumRx and Uptake Medical Emphysema Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Emphysema Treatment Business of PneumRx and Uptake Medical (2019-2024)
Table 80. PneumRx and Uptake Medical Recent Developments
Table 81. Halozyme Therapeutics Basic Information List
Table 82. Halozyme Therapeutics Description and Business Overview
Table 83. Halozyme Therapeutics Emphysema Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Emphysema Treatment Business of Halozyme Therapeutics (2019-2024)
Table 85. Halozyme Therapeutics Recent Developments
Table 86. Mariposa Health Basic Information List
Table 87. Mariposa Health Description and Business Overview
Table 88. Mariposa Health Emphysema Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Emphysema Treatment Business of Mariposa Health (2019-2024)
Table 90. Mariposa Health Recent Developments
Table 91. Uptake Medical Basic Information List
Table 92. Uptake Medical Description and Business Overview
Table 93. Uptake Medical Emphysema Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Emphysema Treatment Business of Uptake Medical (2019-2024)
Table 95. Uptake Medical Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Emphysema Treatment Downstream Customers
Table 99. Emphysema Treatment Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Emphysema Treatment Product Picture
Figure 2. Global Emphysema Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Emphysema Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Emphysema Treatment Report Years Considered
Figure 5. Global Emphysema Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Emphysema Treatment Revenue in 2023
Figure 7. Emphysema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Centrilobular emphysema Picture
Figure 9. Panlobular emphysema Picture
Figure 10. Global Emphysema Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Emphysema Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinics
Figure 14. Product Picture of Surgical center
Figure 15. Global Emphysema Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Emphysema Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Emphysema Treatment Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Emphysema Treatment Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Emphysema Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Emphysema Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Emphysema Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Emphysema Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Emphysema Treatment Sales Value (%), (2019-2030)
Figure 28. United States Emphysema Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Emphysema Treatment Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Emphysema Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Emphysema Treatment Sales Value by Application (%), 2023 VS 2030
Figure 34. China Emphysema Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. China Emphysema Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Emphysema Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Emphysema Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Emphysema Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Emphysema Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Emphysema Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Emphysema Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. India Emphysema Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Emphysema Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. India Emphysema Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. Emphysema Treatment Industrial Chain
Figure 50. Emphysema Treatment Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data TriangulationDescription
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The global market for Emphysema Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Emphysema Treatment by region & country, by Type, and by Application.
The Emphysema Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Emphysema Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Emphysema Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Emphysema Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
-
The global Emphysema Treatment Medication market size was US$ 4266 million in 2024 and is forecast to a readjusted size of US$ 5331 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 110
USD 4250.00
(Single User License)
-
The global market for Emphysema Treatment Medication was estimated to be worth US$ 4266 million in 2024 and is forecast to a readjusted size of US$ 5331 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 131
USD 3950.00
(Single User License)
-
The global market for Emphysema Treatment Medication was valued at US$ 4266 million in the year 2024 and is projected to reach a revised size of US$ 5331 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-03-12
Pages: 100
USD 2900.00
(Single User License)
-
The global market for Emphysema Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-26
Pages: 104
USD 3950.00
(Single User License)
-
The global market for Emphysema Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-26
Pages: 83
USD 2900.00
(Single User License)
-
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
Published: 2024-04-24
Pages: 131
USD 4900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 94
USD 2900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 133
USD 4350.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 157
USD 4900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 129
USD 3950.00
(Single User License)
0
